Dongin (Donoven) Kim, Ph.D.

---

Publications & Presentations

21. Wang J, Lee J S, Kim D, Zhu L. Exploration of Zinc Oxide Nanoparticles as a Multitarget and Multifunctional Anticancer Nanomedicine. ACS applied materials & interfaces. 2017; 9 : 39971-39984

22. Yao Q, Choi J H, Dai Z, Wang J, Kim D, Tang X, Zhu L. Improving Tumor Specificity and Anticancer Activity of Dasatinib by Dual-Targeted Polymeric Micelles. ACS applied materials & interfaces. 2017; 9 : 36642-36654

23. Yao Q, Dai Z, Hoon Choi J, Kim D, Zhu L. Building Stable MMP2-Responsive Multifunctional Polymeric Micelles by an All-in-One Polymer-Lipid Conjugate for Tumor-Targeted Intracellular Drug Delivery. ACS applied materials & interfaces. 2017; 9 : 32520-32533

24. Yao Q, Gutierrez D C, Hoang N H, Kim D, Wang R, Hobbs C, Zhu L. Efficient Codelivery of Paclitaxel and Curcumin by Novel Bottlebrush Copolymer-based Micelles. Molecular pharmaceutics. 2017; 14 : 2378-2389

25. Alvero A B, Kim D, Lima E, Sumi N J, Lee J S, Cardenas C, Pitruzzello M, Silasi D A, Buza N, Fahmy T, Mor G. Novel approach for the detection of intraperitoneal micrometastasis using an ovarian cancer mouse model. Scientific reports. 2017; 7 : 40989

Grants

1. Extracellular Vesicle-Based Intraocular Therapy Combined with Active Targeting of Ocular Neovascularization. NEI. Start Date: 2024. End Date: 2029.

2. MiPEP133, a New Tumor Suppressor for Ovarian Cancer. American Cancer Society. Start Date: 2024. End Date: 2027.

3. Extracellular Vesicle Therapy for Diabetic Retinopathy. NEI. Start Date: 2023. End Date: 2024.

4. Lymphatics and lymphangiogenesis in kidney function and inflammation. NIH. Start Date: 2019. End Date: 2024.

5. Extracellular Vesicle Therapy for Diabetic Retinopathy. NEI. Start Date: 2023. End Date: 2024.

Awards and Honors

no results

Education

1. Degree: Ph D. University of Utah. Date: 2009.


2. Degree: MS. University of Florida. Date: 2002.


3. Degree: BS. Ajou University. Date: 1999.

Administrative Assignments

no results